Exclusive

Publication

Byline

Location

Takeda Eyes India for Global Clinical Trials to Accelerate Drug Launches

New Delhi, Aug. 22 -- Japanese pharmaceutical giant Takeda Pharmaceutical Co. is actively exploring the possibility of conducting global clinical trials in India, aiming to fast-track the approval and... Read More


Huaweis 1,800-Mile Solid-State EV Battery and $1.4B Luxeed Investment Could Revolutionize the EV Industry

New Delhi, Aug. 13 -- Huawei is making headlines in the electric vehicle (EV) industry with a newly patented solid-state EV battery that promises an extraordinary range of over 1,800 miles (about 3,00... Read More


Indias $200 Billion Electric Vehicle Boom as NITI Aayog Proposes Bold Regulatory Shift

New Delhi, Aug. 6 -- In a game-changing development for India's green mobility push, NITI Aayog has launched a new report unveiling a $200 billion economic opportunity tied to electric vehicle (EV) ad... Read More


Trumps Anti-Woke AI Order Could Redefine AI Model Training Standards

New Delhi, July 25 -- Executive Order Targets Ideological Bias in AI President Donald Trump signed a controversial anti-woke AI executive order aimed at restricting the federal use of artificial inte... Read More


Apera AI Launches Major Update to Forge Platform, Making Vision-Guided Robotics Easier & Faster

New Delhi, July 11 -- Apera AI has released a major update to its Forge platform, designed to simplify one of the most difficult parts of factory automation: setting up robots that can see and underst... Read More


UK Strengthens Defense with F-35A Fighter Jets for Tactical Nuclear Deterrence

New Delhi, June 27 -- The UK government has announced the purchase of F-35A fighter jets from Lockheed Martin, capable of carrying tactical nuclear weapons. This acquisition marks a major step in enha... Read More


Taiwan Joins U.S. in Chip War, Blocks Huawei and SMIC from Advanced Tech Access

New Delhi, June 18 -- In a significant escalation of the global tech rivalry, Taiwan has formally aligned itself with the United States by restricting the export of advanced semiconductor technologies... Read More


AstraZenecas Camizestrant Significantly Delays Breast Cancer Progression in Key Clinical Trial

New Delhi, June 4 -- In a major development unveiled at the 2025 ASCO Annual Meeting, AstraZeneca's camizestrant, an investigational oral SERD (selective estrogen receptor degrader), has demonstrated ... Read More